Document is current
Any future updates will be listed below
-
Authors
Ortí, Guillermo https://orcid.org/0000-0002-7889-5807
Dachy, Guillaume https://orcid.org/0000-0002-1668-975X
Graham, Charlotte E.
Peric, Zinaida
Alarcon, Ana
del Bufalo, Francesca
Doglio, Matteo https://orcid.org/0000-0003-2477-2139
Henter, Jan-Inge
Roddie, Claire
Stewart, Orla
Van de Donk, W.C.J.
Velasco, Roser
Aljurf, Mahmoud https://orcid.org/0000-0003-3942-7370
Ruggeri, Annalisa https://orcid.org/0000-0002-7261-2765
Onida, Francesco https://orcid.org/0000-0002-2991-3474
Sánchez-Ortega, Isabel https://orcid.org/0009-0005-5519-9154
Yakoub-Agha, Ibrahim https://orcid.org/0000-0003-4524-8782
Penack, Olaf https://orcid.org/0000-0003-4876-802X
- License Information
-
More Information
Article History
Received: 28 October 2024
Revised: 13 March 2025
Accepted: 24 March 2025
First Online: 9 April 2025
Competing interests
: GO has received consulting fees from BMS, Incyte, Norvartis, Pfizer, and Sanofi; travel support from BMS, Incyte, Norvartis, and Sanofi; institutional research grant from Incyte; and honoraria from BMS, Incyte, Jazz, Norvartis, Pfizer, and Sanofi. GD received honoraria from Kite/Gilead, BMS. JIH: consultant for Sobi. FdB received support from the Italian Ministry of Health (project code: GR-2021-12372614). N.W.C.J.v.d.D. has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, Novartis, Cellectis, and BMS, and serves in advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, Sanofi, Takeda, Roche, Novartis, Bayer, Adaptive, Merck, Kite Pharma, Pfizer, AbbVie, and Servier, all paid to institution. RV: has received consulting fees from Takeda, Novartis, Kite/ Gilead, and Seagen; received honoraria from Takeda, Janseen, and Kite/Gilead, and travel grants from Takeda and Kite/Gilead. IYA received honoraria from Kite/Gilead, BMS, Novartis, Janssen. OP has received honoraria or travel support from Alexion, Gilead, Jazz, MSD, Neovii, Novartis, Pfizer, and Therakos. He has received research support from Incyte and Priothera. He is member of advisory boards to Apogepha, Alexion, Equillium Bio, Jazz, Gilead, Novartis, MSD, Omeros, Orca Bio, Priothera, Sanofi, Shionogi, and SOBI.
